Biostasis Technologies IncPub 78
Pub 78
Balance Sheet
Fiscal Year: 2025
Assets in 2025 (Year End)
$155,286
Property, Plant, & Equipment (net)
56%
Cash & Equivalents
33%
Other Assets
7%
Prepaid Expenses
4%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Liabilities in 2025 (Year End)
$400
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$276,954
$50,796
-82%
Receivables (Non-Related)
$0
$0
-
Related-Party Receivables
$36,866
$0
-100%
Inventories
$0
$0
-
Prepaid Expenses
$0
$6,010
-
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$71,603
$87,480
+22%
Other Assets
$11,000
$11,000
+0%
Total Assets
$396,423
$155,286
-61%
Liabilities
2024
2025
Change
Payables & Accruals
$46,646
$400
-99%
Grants Payable
$0
$0
-
Deferred Revenue
$296,719
$0
-100%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$0
$0
-
Total Liabilities
$343,365
$400
-100%
Net assets
2024
2025
Change
Restricted Net Assets
$0
$0
-
Unrestricted Net Assets
$53,058
$154,886
+192%
Net assets
2024
2025
Change
Net assets
+$53,058
+$154,886
+192%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)